June 28, 2019
Pfizer gets U.S. FDA approval for its oncology biosimilar, ZIRABEV
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration(FDA) has approved ZIRABEV™ (bevacizumab-bvzr), a…